In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Psychiatry

• Publication date

  2015-07-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1176/appi.ajp.2015.14081031PMID 26133962PMCID PMC5070491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Number of Tables : 2 Number of Figures : 4 Supplemental Information : 0

  2016cited by this paper
• Acute increases in synaptic GABA detectable in the living human brain: a [C]Ro15-4513 PET study

  2014cited by this paper
• Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia.

  2014cited by this paper
• Acute increases in synaptic GABA detectable in the living human brain: A [11C]Ro15-4513 PET study

  2014cited by this paper
• In vivo measurements of glutamate, GABA, and NAAG in schizophrenia.

  2013cited by this paper
• Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.

  2013cited by this paper
• Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

  2012cited by this paper
• Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.

  2012cited by this paper
• [11C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels

  2012cited by this paper
• Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

  2012cited by this paper
• From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

  2012cited by this paper
• GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.

  2010cited by this paper
• GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression

  2010cited by this paper
• Elevated gamma-aminobutyric acid levels in chronic schizophrenia.

  2010cited by this paper
• Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects

  2009cited by this paper
• Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

  2009cited by this paper
• Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

  2009cited by this paper
• Measurement of GABAA receptor binding in vivo with [11C]Flumazenil: A test-retest study in healthy subjects

  2008cited by this paper
• GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for α5 subunit

  2008cited by this paper
• The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

  2008cited by this paper
• GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for alpha5 subunit.

  2008cited by this paper
• Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks

  2007cited by this paper
• Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.

  2005cited by this paper
• Cortical inhibitory neurons and schizophrenia

  2005cited by this paper
• Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

  2005cited by this paper
• Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation.

  2004cited by this paper
• Gamma oscillations correlate with working memory load in humans.

  2003cited by this paper
• Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.

  2002cited by this paper
• Cortical γ-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder: A Proton Magnetic Resonance Spectroscopy Study

  2002cited by this paper
• Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study.

  2001cited by this paper
• Dysfunction of early-stage visual processing in schizophrenia.

  2001cited by this paper
• Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

  2000cited by this paper
• Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.

  2000cited by this paper
• [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia.

  1999cited by this paper
• Oscillatory gamma activity in humans and its role in object representation.

  1999cited by this paper
• Coherence of gamma-band EEG activity as a basis for associative learning

  1999cited by this paper
• No Evidence of Altered In Vivo Benzodiazepine Receptor Binding in Schizophrenia

  1999cited by this paper
• Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI.

  1999cited by this paper
• Sustained and transient oscillatory responses in the gamma and beta bands in a visual short-term memory task in humans

  1999cited by this paper
• Functional hypofrontality and working memory dysfunction in schizophrenia.

  1998cited by this paper
• Neuronal and glial localization of GAT-1, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex.

  1998cited by this paper
• Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory study.

  1997cited by this paper
• Parametric Images of Benzodiazepine Receptor Concentration Using a Partial-Saturation Injection

  1997cited by this paper
• Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain.

  1997cited by this paper
• Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.

  1997cited by this paper
• Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

  1996cited by this paper
• Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia.

  1996cited by this paper
• Am J Psychiatry

  1996cited by this paper
• Prefrontal function in schizophrenia: confounds and controversies.

  1996cited by this paper
• Visual feature integration and the temporal correlation hypothesis.

  1995cited by this paper
• SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms.

  1994cited by this paper
• When inhibition not excitation synchronizes neural firing

  1994cited by this paper
• The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study.

  1994cited by this paper
• Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses?

  1993cited by this paper
• Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil

  1993cited by this paper
• The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

  1992cited by this paper
• Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London.

  1992cited by this paper
• Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography

  1991cited by this paper
• Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

  1988cited by this paper
• 'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA.

  1988cited by this paper
• [3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs.

  1987cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

  1986cited by this paper
• GABAergic modulation of benzodiazepine binding site sensitivity

  1978cited by this paper
• High densities of benzodiazepine receptors in human cortical areas

  1977cited by this paper
• Benzodiazepine receptor: demonstration in the central nervous system

  1977cited by this paper
• Compartmental Analysis

  1970cited by this paper
• Neuroimage: Clinical Gaba Level, Gamma Oscillation, and Working Memory Performance in Schizophrenia

  year unknowncited by this paper

• Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review

  2025cites this paper
• Network-based Molecular Constraints on in vivo Synaptic Density Alterations in Schizophrenia

  2025cites this paper
• GABAA receptor availability in clinical high-risk and first-episode psychosis: a Ro15-4513 positron emission tomography study

  2025cites this paper
• Targeting GABAergic Hypofunction Associated with Schizophrenia: Identification of α1β2γ2GABA‑A Receptor Ligands with Neuroprotective and Antipsychotic Properties

  2025cites this paper
• The ventral midline thalamus: participation in neurological and neuropsychiatric disorders.

  2025cites this paper
• GABAA receptor availability in clinical high-risk and first-episode psychosis: a [11C]Ro15-4513 positron emission tomography study

  2025cites this paper
• The immediate alteration of cerebellar Glx/GABA and cerebello-thalamo-cortical connectivity in patients with schizophrenia after cerebellar TMS

  2025cites this paper
• Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis

  2025cites this paper
• Age‐related changes in behavior profile in male offspring of rats treated with poly I:C‐induced maternal immune activation in early gestation

  2024cites this paper
• Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis

  2024cites this paper
• Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis

  2024cites this paper
• Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review.

  2023cites this paper
• The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings.

  2023cites this paper
• Trends in the multiple prescriptions of hypnotic drugs in a university outpatient in Japan

  2023cites this paper
• GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex: simultaneous fMRI/PET with [11C]flumazenil

  2023cites this paper
• Selectively Probing the Magnetic Resonance Signals of γ‐Aminobutyric Acid in Human Brains In Vivo

  2023cites this paper
• A draft conceptual model of SLC6A1 neurodevelopmental disorder

  2023cites this paper
• Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis

  2022cites this paper
• Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis.

  2022cites this paper
• Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes

  2022cites this paper
• The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia

  2022cites this paper
• At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A

  2022cites this paper
• Cellular and molecular signatures of in vivo imaging measures of GABAergic neurotransmission in the human brain

  2022cites this paper
• Erbb4 deletion from fast-spiking interneurons causes psychosis-relevant neuroimaging phenotypes

  2022cites this paper
• Region‐specific associations between gamma‐aminobutyric acid A receptor binding and cortical thickness in high‐functioning autistic adults

  2022cites this paper
• Investigating neurophysiological effects of a short course of tDCS for cognition in schizophrenia: a target engagement study.

  2022cites this paper
• Investigating neurophysiological markers of impaired cognition in schizophrenia.

  2021cites this paper
• Inhibitory and excitatory neurotransmitter systems in depressed and healthy: A positron emission tomography and magnetic resonance spectroscopy study.

  2021cites this paper
• The Amygdala, Hippocampus, Fornix and Nucleus Basalis

  2021cites this paper
• Behavioral Alterations and Decreased Number of Parvalbumin-Positive Interneurons in Wistar Rats after Maternal Immune Activation by Lipopolysaccharide: Sex Matters

  2021cites this paper
• Dissecting the neurobiology of linguistic disorganisation and impoverishment in schizophrenia.

  2021cites this paper
• Molecular imaging of schizophrenia: neurochemical findings in a heterogeneous and evolving disorder.

  2020cites this paper
• Schizophrenia-like behavior is not altered by melatonin supplementation in rodents.

  2020cites this paper
• Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice

  2020cites this paper
• Frontal GABA in schizophrenia: A meta-analysis of 1H-MRS studies

  2020cites this paper
• Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia

  2020cites this paper
• Bolus infusion scheme for the adjustment of steady state [11C]Flumazenil levels in the grey matter and in the blood plasma for neuroreceptor imaging

  2020cites this paper
• Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development

  2020cites this paper
• GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513

  2020cites this paper
• Impaired theta phase coupling underlies frontotemporal dysconnectivity in schizophrenia

  2020cites this paper
• Molecular Imaging

  2020cites this paper
• Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution.

  2020cites this paper
• Neuroimaging in Schizophrenia

  2020cites this paper
• In vivo gamma‐aminobutyric acid‐A/benzodiazepine receptor availability and genetic liability in asymptomatic individuals with high genetic loading of schizophrenia: A [11C]flumazenil positron emission tomography study

  2020cites this paper
• GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia

  2019cites this paper
• Alterations in cortical interneurons and cognitive function in schizophrenia.

  2019cites this paper
• Positron emission tomography imaging of the γ-aminobutyric acid system.

  2019cites this paper
• Sex-Specific Proteomic Changes Induced by Genetic Deletion of Fibroblast Growth Factor 14 (FGF14), a Regulator of Neuronal Ion Channels

  2019cites this paper
• Yoga: Balancing the excitation-inhibition equilibrium in psychiatric disorders.

  2019cites this paper
• The etiological contribution of GABAergic plasticity to the pathogenesis of neuropathic pain

  2019cites this paper
• The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy

  2019cites this paper
• The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.

  2019cites this paper
• Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies

  2019cites this paper
• Amelioration of cognitive impairments induced by GABA hypofunction in the male rat prefrontal cortex by direct and indirect dopamine D1 agonists SKF-81297 and d-Govadine.

  2019cites this paper
• Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

  2019cites this paper
• Functional consequences of Setd1a haploinsufficiency : from gestation to behaviour

  2019cites this paper
• Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain

  2019cites this paper
• Association between Cortical GABA and Loudness Dependence of Auditory Evoked Potentials (LDAEP) in Humans

  2018cites this paper
• Alterations of GABAergic Neuron-Associated Extracellular Matrix and Synaptic Responses in Gad1-Heterozygous Mice Subjected to Prenatal Stress

  2018cites this paper
• Voltage gated N-type Ca-channels in Neurogliaform interneurons in the rat Prefrontal Cortex

  2018cites this paper
• Can we use mice to study schizophrenia?

  2018cites this paper
• Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics

  2018cites this paper
• Disinhibition of the prefrontal cortex leads to brain-wide increases in neuronal activation that are modified by spatial learning

  2018cites this paper
• Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia.

  2018cites this paper
• The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases

  2018cites this paper
• Prefrontal cortical GABAergic regulation of cognition : implications for schizophrenia & other psychiatric disorders

  2018influential citation
• Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective.

  2017cites this paper
• Investigating the neurobiology of schizophrenia and other major psychiatric disorders with Transcranial Magnetic Stimulation.

  2017cites this paper
• Evaluation of short interval cortical inhibition and intracortical facilitation from the dorsolateral prefrontal cortex in patients with schizophrenia

  2017cites this paper
• PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy

  2017cites this paper
• Mechanisms underlying executive function deficits

  2017cites this paper
• PET studies on the mechanisms of action of antidepressant and antipsychotic drugs

  2017cites this paper
• Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders.

  2017cites this paper
• Schizophrenia and neurogenesis: A stem cell approach.

  2017cites this paper
• Regulation of sustained attention, false alarm responding and implementation of conditional rules by prefrontal GABAA transmission: comparison with NMDA transmission

  2017cites this paper
• Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.

  2017cites this paper
• Combination of behaviorally sub‐effective doses of glutamate NMDA and dopamine D1 receptor antagonists impairs executive function

  2017cites this paper
• Impaired theta-gamma coupling during working memory performance in schizophrenia.

  2017cites this paper
• CSF GABA is reduced in first-episode psychosis and associates to symptom severity

  2017cites this paper
• Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis

  2017cites this paper
• GABA metabolism and its role in gamma‐band oscillatory activity during auditory processing: An MRS and EEG study

  2017cites this paper
• Prefrontal cortical GABAergic and NMDA glutamatergic regulation of delayed responding

  2017cites this paper
• GABA and schizophrenia: Where we stand and where we need to go.

  2017cites this paper
• Treatment of Benzodiazepine Dependence

  2017cites this paper
• Motivational Deficits in Schizophrenia

  2016cites this paper
• Deficits in GABAA receptor function and working memory in non-smokers with schizophrenia.

  2016cites this paper
• Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor

  2016cites this paper
• Response to de la Fuente-Sandoval: Challenges Measuring GABA Levels in Patients With Psychosis.

  2016cites this paper
• Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia.

  2016cites this paper
• Brain GABA Function and Psychosis.

  2016cites this paper
• Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities

  2016cites this paper
• Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings.

  2016cites this paper
• Tuning noninvasive brain stimulation with MRI to cope with intersubject variability.

  2016cites this paper
• Epigenetic Basis of Mental Illness

  2016cites this paper
• Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia

  2016cites this paper
• Multisensory Integration Impairment in Rodent Models of Schizophrenia: Converging Evidence for Remediation by Nicotinic Receptor Stimulation of the GABAergic System

  2016cites this paper
• An investigation of the link between cortical inhibition, neural oscillations and psychophysics in schizophrenia

  2016cites this paper
• Brain GABA levels across psychiatric disorders: A systematic literature review and meta‐analysis of 1H‐MRS studies

  2016cites this paper
• Molecules and psychiatry.

  2015cites this paper
• Imaging the "GABA shift" in schizophrenia.

  2015cites this paper